Hedia

Hedia is a Danish startup with a vision to improve the quality of life for people with diabetes by making the best diabetes management tools accessible to a wider audience. Their flagship product, the Hedia Diabetes Assistant (HDA), is a class IIb medical device designed to enhance the management of insulin-requiring diabetes and stabilize blood glucose levels. By analyzing individual habits and personalized input, HDA provides tailored insulin recommendations, thus assisting individuals with their treatment. In addition to their diabetes management tool, Hedia also offers an education platform for healthcare professionals. Founded in 2015, Hedia operates in the fields of AI, Life Sciences, and Medical Devices. Their recent milestone includes a kr22.50M Seed Round investment on 23 February 2024. Although the specific investors for this round are not mentioned, the company has developed its platform in close collaboration with patients, nurses, and other key stakeholders to ensure a fit for living with diabetes. Hedia's vision and strategic positioning in the healthcare industry make it a promising contender in the diabetes management landscape.